[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 016″]
Prior to starting Ocular Therapeutix, Amar Sawhney, already a successful medtech entrepreneur, was a bit concerned about the unique challenges posed by the ophthalmology sector. Today, with the commercial launch of its ReSure Sealant underway and a successful IPO completed, Sawhney says he’s more than confident in the plan to build OCUL into a significant ophthalmic player.
Amar Sawhney, PhD
Amarpreet Sawhney, Ph.D., co-founded Ocular Therapeautix in 2006, has since served as President and CEO and was elected Chairman of the Board in 2014. Dr. Sawhney served as CEO of Augmenix, from 2008 until 2014 and is a general partner of Incept, LLC, an intellectual property holding company.